triazoles has been researched along with ly-2157299 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barra, G; Belli, V; Blauensteiner, B; Cardone, C; Ciaramella, V; Ciardiello, D; Ciardiello, F; Corte, CD; Cuomo, A; De Falco, V; Franco, R; Giunta, EF; Marino, FZ; Martinelli, E; Martini, G; Matrone, N; Mohr, T; Morgillo, F; Napolitano, S; Poliero, L; Selvaggi, F; Sibilia, M; Troiani, T; Vitiello, PP | 1 |
1 other study(ies) available for triazoles and ly-2157299
| Article | Year |
|---|---|
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype.
Topics: Adenocarcinoma; Aged; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Computational Biology; Databases, Genetic; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Pyrazoles; Quinolines; Receptor Protein-Tyrosine Kinases; Receptor, Transforming Growth Factor-beta Type II; Signal Transduction; Spheroids, Cellular; Triazoles | 2021 |